Atrás
Rango del Día
$22.00
$22.00
Rango de 52 Semanas
$19.17
$83.00
Volumen
200
Promedio 50D / 200D
$40.52
/
$49.15
Cierre Anterior
$25.57
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 6.9 | 0.4 |
| P/B | 0.5 | 2.9 |
| ROE % | 7.4 | 3.7 |
| Net Margin % | 5.4 | 3.8 |
| Rev Growth 5Y % | 9.5 | 10.0 |
| D/E | 0.9 | 0.2 |
Puntos Clave
Revenue grew 9.45% annually over 5 years — modest growth
Negative free cash flow of -129.51M
P/E of 6.93 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.17%
Crecimiento
Revenue Growth (5Y)
9.45%
Revenue (1Y)2.28%
Earnings (1Y)-5.52%
FCF Growth (3Y)N/A
Calidad
Return on Equity
7.42%
ROIC5.30%
Net Margin5.39%
Op. Margin9.70%
Seguridad
Debt / Equity
0.85
Current Ratio1.01
Interest Coverage3.26
Valoración
P/E Ratio
6.93
P/B Ratio0.50
EV/EBITDA9.40
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.28% | Revenue Growth (3Y) | 5.85% |
| Earnings Growth (1Y) | -5.52% | Earnings Growth (3Y) | 6.84% |
| Revenue Growth (5Y) | 9.45% | Earnings Growth (5Y) | 5.50% |
| Profitability | |||
| Revenue (TTM) | 2.04B | Net Income (TTM) | 109.72M |
| ROE | 7.42% | ROA | 2.88% |
| Gross Margin | 29.85% | Operating Margin | 9.70% |
| Net Margin | 5.39% | Free Cash Flow (TTM) | -129.51M |
| ROIC | 5.30% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.85 | Current Ratio | 1.01 |
| Interest Coverage | 3.26 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 6.93 | P/B Ratio | 0.50 |
| P/S Ratio | 0.37 | PEG Ratio | -2.70 |
| EV/EBITDA | 9.40 | Dividend Yield | 0.02% |
| Market Cap | 759.88M | Enterprise Value | 1.86B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2.04B | 1.99B | 1.82B | 1.50B | 1.42B |
| Net Income | 109.72M | 116.13M | 96.12M | 83.79M | 88.56M |
| EPS (Diluted) | 3.18 | 3.48 | 3.06 | 2.67 | 2.82 |
| Gross Profit | 607.77M | 597.31M | 546.81M | 442.23M | 437.61M |
| Operating Income | 197.47M | 213.39M | 169.31M | 147.44M | 156.46M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3.81B | 3.43B | 3.35B | 2.88B | 2.62B |
| Total Liabilities | 2.27B | 1.96B | 2.08B | 1.88B | 1.72B |
| Shareholders' Equity | 1.51B | 1.45B | 1.24B | 981.32M | 883.83M |
| Total Debt | 1.28B | 1.04B | 1.22B | 1.13B | 1.05B |
| Cash & Equivalents | 186.38M | 122.34M | 112.79M | 114.05M | 87.95M |
| Current Assets | 992.30M | 849.57M | 810.14M | 657.18M | 551.37M |
| Current Liabilities | 985.50M | 957.97M | 1.10B | 885.78M | 579.46M |